Haas Jason 4
4 · Syros Pharmaceuticals, Inc. · Filed Nov 20, 2024
Insider Transaction Report
Form 4
Haas Jason
Chief Financial Officer
Transactions
- Sale
Common Stock
2024-11-18$0.21/sh−137,803$28,980→ 0 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.19 to $0.2295, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.